Feb. 14, 2003 — The market for microarray technologies could reach $5 billion by 2010, according to a new study.
The study by Kalorama Information, U.S. Markets in Analytical Chip Technology, said the market will find broad applications across the spectrum of life science research and clinical practice. But the near-term opportunities come in drug discovery and development.
The study also notes the market will involve more than just the microarrays themselves. It includes surface technologies for the production of stable microarrays, microarray services, as well as genomic and proteomic databases.
The 410-page report costs $3,500.